Morphine Suppresses Tumor Angiogenesis through a HIF-1α/p38MAPK Pathway
- 31 August 2010
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 177 (2), 984-997
- https://doi.org/10.2353/ajpath.2010.090621
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA114340, F31-DA021005-01, KO2 DA 015349, P50 DA 011806, RO1 DA 022935, RO1 DA 12104)
- National Institute on Drug Abuse
This publication has 37 references indexed in Scilit:
- Social isolation dysregulates endocrine and behavioral stress while increasing malignant burden of spontaneous mammary tumorsProceedings of the National Academy of Sciences of the United States of America, 2009
- Surgical Stress Promotes Tumor Growth in Ovarian CarcinomaClinical Cancer Research, 2009
- Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor κB transcriptional activation in neuroblastoma SH-SY5Y cellsBiochemical Journal, 2007
- Hypoxia: A key regulator of angiogenesis in cancerCancer and Metastasis Reviews, 2007
- Rapid and simple comparison of messenger rna levels using real-time PCRBiological Procedures Online, 2006
- Parenteral Morphine Prescribing Patterns Among Inpatients With Pain From Advanced Cancer: A Prospective Survey of Intravenous and Subcutaneous UseAmerican Journal of Hospice and Palliative Medicine®, 2006
- Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: Role of receptor transactivationMicrovascular Research, 2006
- The subtle side to hypoxia inducible factor (HIFα) regulationEuropean Journal of Biochemistry, 2003
- Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patientsPain, 1995
- Angiogenesis: Modulation with opioidsGeneral Pharmacology: The Vascular System, 1991